Steris PLC (STE) Holdings Lifted by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. boosted its stake in shares of Steris PLC (NYSE:STE) by 6.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,625 shares of the medical equipment provider’s stock after acquiring an additional 1,441 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Steris were worth $2,932,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in STE. Bank of New York Mellon Corp increased its stake in shares of Steris by 1.1% in the third quarter. Bank of New York Mellon Corp now owns 1,040,826 shares of the medical equipment provider’s stock valued at $119,070,000 after buying an additional 10,838 shares in the last quarter. Eagle Asset Management Inc. increased its stake in shares of Steris by 13.3% in the third quarter. Eagle Asset Management Inc. now owns 28,454 shares of the medical equipment provider’s stock valued at $3,255,000 after buying an additional 3,332 shares in the last quarter. Zeke Capital Advisors LLC acquired a new stake in shares of Steris in the third quarter valued at $1,420,000. MML Investors Services LLC increased its stake in shares of Steris by 159.8% in the third quarter. MML Investors Services LLC now owns 19,462 shares of the medical equipment provider’s stock valued at $2,226,000 after buying an additional 11,971 shares in the last quarter. Finally, Parametrica Management Ltd acquired a new stake in Steris in the third quarter worth about $344,000. Hedge funds and other institutional investors own 88.35% of the company’s stock.

Shares of STE stock opened at $113.94 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.63 and a quick ratio of 2.01. The stock has a market capitalization of $10.07 billion, a P/E ratio of 27.46 and a beta of 1.05. Steris PLC has a 12 month low of $82.88 and a 12 month high of $121.67.

Steris (NYSE:STE) last announced its quarterly earnings data on Tuesday, November 6th. The medical equipment provider reported $1.10 EPS for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.02. The firm had revenue of $679.00 million during the quarter, compared to analyst estimates of $659.14 million. Steris had a return on equity of 12.15% and a net margin of 11.72%. The company’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the company earned $0.94 earnings per share. Equities analysts anticipate that Steris PLC will post 4.78 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 21st. Investors of record on Wednesday, November 28th will be given a $0.34 dividend. The ex-dividend date is Tuesday, November 27th. This represents a $1.36 dividend on an annualized basis and a yield of 1.19%. Steris’s payout ratio is 32.77%.

In other Steris news, insider Michael J. Tokich sold 34,500 shares of the firm’s stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $119.16, for a total transaction of $4,111,020.00. Following the transaction, the insider now owns 64,958 shares in the company, valued at $7,740,395.28. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, November 7th. The stock was sold at an average price of $120.50, for a total value of $1,205,000.00. The disclosure for this sale can be found here. 2.38% of the stock is owned by company insiders.

STE has been the subject of a number of research reports. Zacks Investment Research upgraded Steris from a “sell” rating to a “hold” rating in a research report on Wednesday, August 22nd. KeyCorp lifted their price objective on Steris from $120.00 to $132.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 13th. Finally, Sidoti lifted their price objective on Steris from $155.00 to $157.00 and gave the stock a “buy” rating in a research report on Thursday. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $124.71.

TRADEMARK VIOLATION NOTICE: This news story was published by American Banking News and is the property of of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2018/12/08/steris-plc-ste-holdings-lifted-by-pnc-financial-services-group-inc.html.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Read More: Understanding debt-to-equity ratio in fundamental analysis

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply